Advertisement
Screener

LIFECORE BIOMEDICAL, INC. (LFCR) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.9 / 5 stars · 43/114 Roast Me

LIFECORE BIOMEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

LIFECORE BIOMEDICAL, INC. (LFCR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 8.78 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-05

  • LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
  • LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 8.78K shares.
  • LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 59.58K shares.
  • LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-05-25 was 210.00K shares, a 9900.00% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 755.77K shares, a 8897.32% increase from fiscal 2024.
  • LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 8.40K shares, a 98.87% decline from fiscal 2023.
  • LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 743.05K shares, a 7.47% decline from fiscal 2022.
  • LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 803.00K shares, a 17.64% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 7 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
8.78K shares
10-Q · filed 2026-08-05
2026-03-318.78K shares
10-Q · filed 2026-05-06
2025-12-31376.99K shares
10-KT · filed 2026-03-16
2025-09-3059.58K shares
10-Q · filed 2025-11-06
2025-05-25210.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-07
660.25K shares
derived: sum of 2 quarters · filed 2025-08-07
701.63K shares
derived: sum of 3 quarters · filed 2025-08-07
755.77K shares
10-K · filed 2025-08-07
2025-02-23450.25K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03
491.63K shares
derived: sum of 2 quarters · filed 2025-04-03
545.77K shares
10-Q · filed 2025-04-03
547.88K shares
derived: sum of 4 quarters · filed 2025-04-03
2024-11-2441.38K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02
95.53K shares
10-Q · filed 2025-01-02
97.63K shares
derived: sum of 3 quarters · filed 2025-01-02
101.83K shares
derived: sum of 4 quarters · filed 2025-01-02
2024-08-2554.15K shares
10-Q · filed 2024-10-04
56.25K shares
derived: sum of 2 quarters · filed 2024-10-04
60.45K shares
derived: sum of 3 quarters · filed 2024-10-04
60.45K shares
derived: sum of 4 quarters · filed 2024-10-04
2024-05-262.10K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26
6.30K shares
derived: sum of 2 quarters · filed 2024-08-26
6.30K shares
derived: sum of 3 quarters · filed 2024-08-26
8.40K shares
10-K · filed 2024-08-26
2024-02-254.20K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09
4.20K shares
derived: sum of 2 quarters · filed 2024-08-09
6.30K shares
10-Q · filed 2024-08-09
6.30K shares
derived: sum of 4 quarters · filed 2024-08-09
2023-11-260.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
2.10K shares
10-Q · filed 2024-08-09
2.10K shares
derived: sum of 3 quarters · filed 2024-08-09
2.10K shares
derived: sum of 4 quarters · filed 2024-08-09
2023-08-272.10K shares
10-Q · filed 2024-08-09
2.10K shares
derived: sum of 2 quarters · filed 2024-08-09
2.10K shares
derived: sum of 3 quarters · filed 2024-08-09
19.95K shares
derived: sum of 4 quarters · filed 2024-08-09
2023-05-280.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
0.00 shares
derived: sum of 2 quarters · filed 2024-03-20
17.85K shares
derived: sum of 3 quarters · filed 2024-03-20
743.05K shares
10-K · filed 2024-03-20
2023-02-260.00 shares
10-Q · filed 2023-06-02
17.85K shares
derived: sum of 2 quarters · filed 2023-06-02
743.05K shares
10-Q · filed 2023-06-02
767.85K shares
derived: sum of 4 quarters · filed 2024-03-20
2022-11-2717.85K shares
10-Q · filed 2023-03-16
743.05K shares
10-Q · filed 2023-03-16
767.85K shares
derived: sum of 3 quarters · filed 2024-03-20
842.85K shares
derived: sum of 4 quarters · filed 2024-03-20
2022-08-28725.00K shares
10-Q/A · filed 2023-03-16
750.00K shares
derived: sum of 2 quarters · filed 2024-03-20
825.00K shares
derived: sum of 3 quarters · filed 2024-03-20
825.00K shares
derived: sum of 4 quarters · filed 2024-03-20
2022-05-2925.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
100.00K shares
derived: sum of 2 quarters · filed 2024-03-20
100.00K shares
derived: sum of 3 quarters · filed 2024-03-20
803.00K shares
10-K · filed 2024-03-20
2022-02-2775.00K shares
10-Q · filed 2022-04-07
75.00K shares
derived: sum of 2 quarters · filed 2022-04-07
778.00K shares
10-Q · filed 2022-04-07
-671.14M shares
derived: sum of 4 quarters · filed 2024-03-20
2021-11-280.00 shares
10-Q · filed 2022-01-07
703.00K shares
10-Q · filed 2022-01-07
-671.21M shares
derived: sum of 3 quarters · filed 2024-03-20
-571.21M shares
derived: sum of 4 quarters · filed 2024-03-20
2021-08-29703.00K shares
10-Q · filed 2021-10-05
-671.21M shares
derived: sum of 2 quarters · filed 2024-03-20
-571.21M shares
derived: sum of 3 quarters · filed 2024-03-20
-571.19M shares
derived: sum of 4 quarters · filed 2024-03-20
2021-05-30-671.92M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
-571.92M shares
derived: sum of 2 quarters · filed 2024-03-20
-571.90M shares
derived: sum of 3 quarters · filed 2024-03-20
682.60K shares
10-K · filed 2024-03-20
2021-02-28100.00M shares
10-Q · filed 2021-04-08
100.02M shares
derived: sum of 2 quarters · filed 2021-04-08
672.60M shares
10-Q · filed 2021-04-08
100.75M shares
derived: sum of 4 quarters · filed 2023-03-16
2020-11-2921.00K shares
10-Q · filed 2021-01-07
573.00K shares
10-Q · filed 2021-01-07
752.60K shares
derived: sum of 3 quarters · filed 2023-03-16
947.60K shares
derived: sum of 4 quarters · filed 2023-03-16
2020-08-30551.60K shares
10-Q · filed 2020-10-07
731.60K shares
derived: sum of 2 quarters · filed 2023-03-16
926.60K shares
derived: sum of 3 quarters · filed 2023-03-16
986.60K shares
derived: sum of 4 quarters · filed 2023-03-16
2020-05-31180.00K shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16
375.00K shares
derived: sum of 2 quarters · filed 2023-03-16
435.00K shares
derived: sum of 3 quarters · filed 2023-03-16
435.00K shares
10-K/A · filed 2023-03-16
2020-02-23195.00K shares
10-Q · filed 2020-04-03
255.00K shares
derived: sum of 2 quarters · filed 2020-04-03
255.00K shares
10-Q · filed 2020-04-03
417.26K shares
derived: sum of 4 quarters · filed 2021-07-29
2019-11-2460.00K shares
10-Q · filed 2020-01-02
60.00K shares
10-Q · filed 2020-01-02
222.26K shares
derived: sum of 3 quarters · filed 2021-07-29
253.26K shares
derived: sum of 4 quarters · filed 2021-07-29
2019-08-250.00 shares
10-Q · filed 2019-10-03
162.26K shares
derived: sum of 2 quarters · filed 2021-07-29
193.26K shares
derived: sum of 3 quarters · filed 2021-07-29
238.26K shares
derived: sum of 4 quarters · filed 2021-07-29
2019-05-26162.26K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29
193.26K shares
derived: sum of 2 quarters · filed 2021-07-29
238.26K shares
derived: sum of 3 quarters · filed 2021-07-29
368.26K shares
10-K · filed 2021-07-29
2019-02-2431.00K shares
10-Q · filed 2019-04-04
76.00K shares
derived: sum of 2 quarters · filed 2019-04-04
206.00K shares
10-Q · filed 2019-04-04
206.00K shares
derived: sum of 4 quarters · filed 2020-08-14
2018-11-2545.00K shares
10-Q · filed 2019-01-07
175.00K shares
10-Q · filed 2019-01-07
175.00K shares
derived: sum of 3 quarters · filed 2020-08-14
175.00K shares
derived: sum of 4 quarters · filed 2020-08-14
2018-08-26130.00K shares
10-Q · filed 2018-10-05
130.00K shares
derived: sum of 2 quarters · filed 2020-08-14
130.00K shares
derived: sum of 3 quarters · filed 2020-08-14
523.00K shares
derived: sum of 4 quarters · filed 2020-08-14
2018-05-270.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14
0.00 shares
derived: sum of 2 quarters · filed 2020-08-14
393.00K shares
derived: sum of 3 quarters · filed 2020-08-14
498.00K shares
10-K · filed 2020-08-14
2018-02-250.00 shares
10-Q · filed 2018-04-05
393.00K shares
derived: sum of 2 quarters · filed 2018-04-05
498.00K shares
10-Q · filed 2018-04-05
498.00K shares
derived: sum of 4 quarters · filed 2019-08-01
2017-11-26393.00K shares
10-Q · filed 2018-01-05
498.00K shares
10-Q · filed 2018-01-05
498.00K shares
derived: sum of 3 quarters · filed 2019-08-01
558.00K shares
derived: sum of 4 quarters · filed 2019-08-01
2017-08-27105.00K shares
10-Q · filed 2017-09-28
105.00K shares
derived: sum of 2 quarters · filed 2019-08-01
165.00K shares
derived: sum of 3 quarters · filed 2019-08-01
165.00K shares
derived: sum of 4 quarters · filed 2019-08-01
2017-05-280.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01
60.00K shares
derived: sum of 2 quarters · filed 2019-08-01
60.00K shares
derived: sum of 3 quarters · filed 2019-08-01
240.00K shares
10-K · filed 2019-08-01
2017-02-2660.00K shares
10-Q · filed 2017-04-07
60.00K shares
derived: sum of 2 quarters · filed 2017-04-07
240.00K shares
10-Q · filed 2017-04-07
2016-11-270.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05
180.00K shares
10-Q · filed 2017-01-05
2016-08-28180.00K shares
10-Q · filed 2016-09-29
2016-02-2830.00K shares
10-Q · filed 2016-03-30
66.00K shares
derived: sum of 2 quarters · filed 2016-03-30
126.00K shares
10-Q · filed 2016-03-30
2015-11-2936.00K shares
10-Q · filed 2016-01-07
96.00K shares
10-Q · filed 2016-01-07
2015-08-3060.00K shares
10-Q · filed 2015-10-01
2015-03-0190.00K shares
10-Q · filed 2015-04-02
90.00K shares
derived: sum of 2 quarters · filed 2015-04-02
120.00K shares
10-Q · filed 2015-04-02
2014-11-300.00 shares
10-Q · filed 2015-01-09
30.00K shares
10-Q · filed 2015-01-09
2014-08-31469.00 shares
10-Q · filed 2014-10-08
2014-02-230.00 shares
10-Q · filed 2014-03-28
0.00 shares
derived: sum of 2 quarters · filed 2014-03-28
291.50K shares
10-Q · filed 2014-03-28
2013-11-240.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03
291.50K shares
10-Q · filed 2014-01-03
2013-08-25291.50K shares
10-Q · filed 2013-09-26
2013-02-2420.00K shares
10-Q · filed 2013-04-04
2012-11-2520.00K shares
10-Q · filed 2013-01-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADC Therapeutics SA (ADCT)$0.163B-1.39
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Annexon, Inc. (ANNX)United States$0.147B-4.22
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Atrium Therapeutics, Inc. (RNA)United States$0.140B